Peter N. Johnson, Pharm.D., BCPPS, FPPAG, FCCM, FASHP
Professor of Pharmacy Practice
Pharmacy Clinical & Admin Sci
Phone (405) 271-2730
Fax (405) 271-6750
Office O'Donoghue Research Bldg; 1122 NE 13th St., Ste. 4415, OKC 73117
Email Peter-Johnson@ouhsc.edu
Summary
- President's Associate Presidential Professor
- Director, PGY2 Pediatric Pharmacy Residency
- Director, Pediatric Pharmacotherapy Degree Option
Publications & Presentations
- 16. Mayes R A, Johnson P N, White B P, Neely S, Chaaban H, Miller J L. Impact of Ceftazidime Use on Susceptibility Patterns in a Neonatal Intensive Care Unit: A 7.5-year Evaluation. Journal of the Pediatric Infectious Diseases Society. 2022; 11 : 349-350
17. Lim S Y, May C B, Johnson P N, Miller J L. Caffeine dosing in premature neonates: impact of birth weight on a pharmacokinetic simulation study. Pediatric research. 2022
18. Taher K W, Johnson P N, Miller J L, Neely S, Gupta N. Efficacy and Safety of Prolonged Magnesium Sulfate Infusions in Children With Refractory Status Asthmaticus. Frontiers in pediatrics. 2022; 10 : 860921
19. Bobo K S, Cober M P, Eiland L S, Heigham M, King M, Johnson P N, Miller J L, Sierra C M. Correction to: Key articles and guidelines for the pediatric clinical pharmacist from 2019 and 2020. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2022; 79 : 823
20. Johnson P N. ICU Psychosis and Delirium. American College of Clinical PHarmacy. 2022 : 101-124
Grants
- 1. Evaluation of caffeine dosing regimens and the impact of developmental pharmacokinetics in neonates with apnea of prematurity. Misc Non-Federal. Start Date: 2020. End Date: 2021.
2. Characterization of fentanyl metabolic and renal elimination pathways in children less than two years of age. Misc Non-Federal. Start Date: 2018. End Date: 2020.
3. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.
4. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.
5. Comparison of amikacin pharmacokinetics in neonates pre- and post- a dosing protocol change. Misc Non-Federal. Start Date: 2014. End Date: 2015.
Awards and Honors
- 1. Oklahoma Society of Health-System Pharmacists/Oklahoma Pharmacy Residency Research Conference. Oklahoma Residency Research Excellence Award (served as mentor for Dom Ropp). Date: 2023.
2. Oklahoma Society of Health-System Pharmacists/Oklahoma Pharmacy Residency Research Conference. Oklahoma Residency Research Excellence Award (served as mentor for Eugenie Chang). Date: 2023.
3. University of Oklahoma College of Medicine--Department of Pediatrics. Mentor award (for Caitlyn Bradford, PharmD). Date: 2022.
4. University of Oklahoma Health Sciences Center. President's Associates Presidential Professorship. Date: 2019.
5. Pediatric Pharmacy Advocacy Group. Christensen Young Investigator Award (Served as resident mentor). Date: 2016.
Education
- 1. Degree: PGY2 Pediatric Pharmacy Residency. Kentucky Children's Hospital and University of Kentucky Chandler Medical Center. Date: 2006.
2. Degree: PGY1 Pharmacy Residency. University of Kentucky Chandler Medical Center. Date: 2005.
3. Degree: PharmD. University of Mississippi School of Pharmacy. Date: 2004.
4. Degree: BS. University of Mississippi School of Pharmacy. Date: 2002.
Administrative Assignments
no results